Achira is developing atomistic foundation simulation models intended to advance drug discovery. The company's work sits at the intersection of machine learning, quantum chemistry, and biomolecular simulation, aiming to create a new approach to identifying therapeutic compounds.
The technical scope at Achira spans several disciplines, including geometric deep learning, statistical mechanics, physics-based simulation, and computer-aided drug discovery. The team's stated goal is to combine the rigor of physics-based methods with the flexibility of modern machine learning techniques.
Achira operates within the pharmaceutical and drug discovery sectors. The company describes its culture as oriented toward harmonizing theoretical research with practical application, driven by an ambition to establish fundamentally new methods for discovering medicines.
